How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.

Slides:



Advertisements
Similar presentations
Volume 64, Issue 3, Pages (September 2013)
Advertisements

Volume 58, Issue 2, Pages (August 2010)
Volume 55, Issue 3, Pages (March 2009)
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Epidemiology and Risk Factors of Urothelial Bladder Cancer
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.
European Urology Oncology
Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)
Volume 69, Issue 1, Pages (January 2016)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 
Volume 51, Issue 3, Pages (March 2007)
Volume 69, Issue 2, Pages (February 2016)
Volume 60, Issue 1, Pages (July 2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis  Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,
Re: Marcus G. Cumberbatch, Matteo Rota, James W. F
Volume 63, Issue 4, Pages (April 2013)
European Urology Oncology
Volume 63, Issue 1, Pages (January 2013)
Bladder Cancer: A Major Public Health Issue
Nomograms for Bladder Cancer
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Volume 61, Issue 5, Pages (May 2012)
Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis  Mohamad B. Sonbol, Belal Firwana, Talal.
Volume 55, Issue 3, Pages (March 2009)
European Urology Oncology
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
Stephen B. Williams, Ashish M
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Volume 67, Issue 6, Pages (June 2015)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Male patients with non-small cell lung cancer (NSCLC) have a 24% reduction in the risk of disease progression (A). Male patients with non-small cell lung.
Volume 56, Issue 5, Pages (November 2009)
European Urology Oncology
European Urology Oncology
(A) Frequency of synchronous diagnosis of primary tumour and BM according to primary tumour type (B) Frequency of patients with asymptomatic BM at first.
Invasion front (pushing margin) of the patient's tumour from the primary resection showing a high number of tumour-infiltrating leucocytes, which is characteristic.
Volume 50, Issue 4, Pages (October 2006)
Recurrence pattern after initial treatment of brain metastases and cause of death. Recurrence pattern after initial treatment of brain metastases and cause.
European Urology Oncology
European Urology Oncology
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.
European Urology Oncology
Sergio Bracarda  European Urology Supplements 
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
European Urology Oncology
The Cost to Medicare of Bladder Cancer Care
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
European Urology Oncology
European Urology Oncology
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
European Urology Oncology
Patients’ most feared AEs reported to be intolerable when lasting more than 7 days at baseline, on study and at study completion (% patients); (A) grade.
European Urology Oncology
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
European Urology Oncology
European Urology Oncology
Efficacy of nivolumab in Japanese patients with advanced non-squamous non-small cell lung cancer (A) Kaplan-Meier curve for PFS, (B) Kaplan-Meier curve.
Maximilian Burger, Ashish M. Kamat, David McConkey 
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.
Presentation transcript:

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James W.F. Catto  European Urology Oncology  DOI: 10.1016/j.euo.2019.07.006 Copyright © 2019 The Author(s) Terms and Conditions

Fig. 1 Correlation of disease progression and mortality with duration of follow-up. MA = meta-analysis. Adapted from Kulkarni et al [15]. European Urology Oncology DOI: (10.1016/j.euo.2019.07.006) Copyright © 2019 The Author(s) Terms and Conditions